Lifeline Biotechnologies Stock Market Value
| LLBO Stock | USD 0.0001 0.0003 75.00% |
| Symbol | Lifeline |
Lifeline Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lifeline Biotechnologies' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lifeline Biotechnologies.
| 11/23/2024 |
| 12/23/2024 |
If you would invest 0.00 in Lifeline Biotechnologies on November 23, 2024 and sell it all today you would earn a total of 0.00 from holding Lifeline Biotechnologies or generate 0.0% return on investment in Lifeline Biotechnologies over 30 days. Lifeline Biotechnologies is related to or competes with Cellink AB, Bone Biologics, BICO Group, Aurora Spine, and Tenon Medical. Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States More
Lifeline Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lifeline Biotechnologies' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lifeline Biotechnologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 63.22 | |||
| Information Ratio | 0.1604 | |||
| Maximum Drawdown | 375.0 | |||
| Value At Risk | (66.67) | |||
| Potential Upside | 100.0 |
Lifeline Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifeline Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lifeline Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Lifeline Biotechnologies historical prices to predict the future Lifeline Biotechnologies' volatility.| Risk Adjusted Performance | 0.1373 | |||
| Jensen Alpha | 10.29 | |||
| Total Risk Alpha | 8.46 | |||
| Sortino Ratio | 0.1617 | |||
| Treynor Ratio | (5.47) |
Lifeline Biotechnologies Backtested Returns
Lifeline Biotechnologies is out of control given 3 months investment horizon. Lifeline Biotechnologies has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. We have analyzed twenty-seven different technical indicators, which can help you to evaluate if expected returns of 10.41% are justified by taking the suggested risk. Use Lifeline Biotechnologies Risk Adjusted Performance of 0.1373, mean deviation of 33.26, and Downside Deviation of 63.22 to evaluate company specific risk that cannot be diversified away. Lifeline Biotechnologies holds a performance score of 12 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.87, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Lifeline Biotechnologies are expected to decrease by larger amounts. On the other hand, during market turmoil, Lifeline Biotechnologies is expected to outperform it. Use Lifeline Biotechnologies total risk alpha and the relationship between the potential upside and price action indicator , to analyze future returns on Lifeline Biotechnologies.
Auto-correlation | -0.04 |
Very weak reverse predictability
Lifeline Biotechnologies has very weak reverse predictability. Overlapping area represents the amount of predictability between Lifeline Biotechnologies time series from 23rd of November 2024 to 8th of December 2024 and 8th of December 2024 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lifeline Biotechnologies price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Lifeline Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lifeline Biotechnologies lagged returns against current returns
Autocorrelation, which is Lifeline Biotechnologies pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lifeline Biotechnologies' pink sheet expected returns. We can calculate the autocorrelation of Lifeline Biotechnologies returns to help us make a trade decision. For example, suppose you find that Lifeline Biotechnologies has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lifeline Biotechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lifeline Biotechnologies pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lifeline Biotechnologies pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lifeline Biotechnologies pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Lifeline Biotechnologies Lagged Returns
When evaluating Lifeline Biotechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lifeline Biotechnologies pink sheet have on its future price. Lifeline Biotechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lifeline Biotechnologies autocorrelation shows the relationship between Lifeline Biotechnologies pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Lifeline Biotechnologies.
Regressed Prices |
| Timeline |
Pair Trading with Lifeline Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifeline Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Lifeline Pink Sheet
| 0.57 | BSX | Boston Scientific Corp | PairCorr |
| 0.48 | EW | Edwards Lifesciences Corp | PairCorr |
| 0.47 | DXCM | DexCom Inc | PairCorr |
| 0.45 | SYK | Stryker | PairCorr |
| 0.43 | BRK-A | Berkshire Hathaway | PairCorr |
The ability to find closely correlated positions to Lifeline Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifeline Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifeline Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifeline Biotechnologies to buy it.
The correlation of Lifeline Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifeline Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifeline Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifeline Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.